Over the past five years, significant progress has propelled the manufacturing of clinical cell therapies toward the feasibility of point-of-care production within academic centers. The transition to a decentralized system has been made possible by advancements in small, adaptable, closed manufacturing devices. Additionally, the range of ancillary reagents essential for large-scale production has expanded, with numerous GMP-grade commercial products now available on the market.

In this webinar, Dr. Julian J. Lum discusses key factors to consider when choosing metabolic assays and how they can be used to assess cell function. Additionally, he discusses the metabolic characteristics of different commercially available cell culture media formulations as well as the importance of assessing the array of media products and their impact on metabolism.

This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts.